Rapamycin

A TruMe Labs Case Study: How Longitudinal Epigenetic Testing Helped One User Detect a High-Dose Protocol Backfire

A TruMe Labs case study reveals how longitudinal epigenetic testing helped a user detect that a high-dose rapamycin protocol was negatively impacting his biological age, leading to a crucial course correction. This highlights the value of objective, dynamic feedback in anti-aging strategies beyond simple vanity metrics.